leadf
logo-loader
viewBATM Advanced Communications Ltd

BATM Advanced Communications lands €4.3mln contract for Covid testing kit with the expectation of more orders to come

“We believe that we will receive further sizeable orders from our existing customers as well as continue to gain new customers for these products," said chief executive, Dr Zvi Marom

BATM Advanced Communications Ltd -

BATM Advanced Communications Ltd (LON:BVC) (TASE:BVC) revealed it has landed a €4.3mln order for its coronavirus (COVID-19) real-time diagnostic kits and instruments.

The group said the customer is an Italian group that provides tests across Europe for businesses such as airports.

BATM said it expects to receive further significant orders from the buyer, both near-term and in the next year.

Being delivered are PCR antigen tests, which diagnose whether someone is currently infected with the virus, and the Ampilab qPCR and Extralab instruments. The Ampilab 6 band qPCR instrument can run all standard test kits, but also advanced gene kits, such as the BATM’s newest COVID-19 antigen kit.

"The substantial interest in these solutions is growing as the pandemic prevails throughout much of the world and we head towards flu season,” BATM chief executive, Dr Zvi Marom said in a statement.

“We believe that we will receive further sizeable orders from our existing customers as well as continue to gain new customers for these products.”

In the same announcement BATM updated on the progress being made with its next generation of testing kits.

It said it has started to deliver its COVID-19 antigen kit that was upgraded to detect the spike protein, which accurately finds those with a low viral load who might unknowingly be spreading the infection.

BATM’s new multi-­pathogen respiratory kit, meanwhile, is in the final validation phase and production and deliveries are expected to commence during the current quarter.

The firm also revealed that production is starting on the group's jointly-developed home test kit for flu after the device was CE certified and validated.

And it said it was making “strong progress” with a jointly-developed COVID-19 home test kit, which is at an advanced development stage.    

"We are also delighted with the progress that we have made with our newly-developed tests for COVID-19, flu and other respiratory disease,” said Marom. “Thanks to our innovative diagnostic platform, we can offer a high-quality comprehensive solution to help protect public health in the current pandemic and beyond."   

Quick facts: BATM Advanced Communications Ltd

Price: 85.8 GBX

LSE:BVC
Market: LSE
Market Cap: £3.8 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of BATM Advanced Communications Ltd named herein, including the promotion by the Company of BATM Advanced Communications Ltd in any Content on the...

FOR OUR FULL DISCLAIMER CLICK HERE

BATM Advanced Communications lands €4m order for Coronavirus diagnostic kits

BATM Advanced Communications (LON:BVC) Zvi Marom speaks to Proactive London's Katie Pilbeam after announcing a €4m order for its coronavirus real-time diagnostic kits. Marom says this is the first order and is expecting 'many more orders very soon' and as a consequence is 'ramping up...

on 5/10/20

2 min read